ArticleEuropean journal of case reports in internal medicine2025
West Nile Virus Neuroinvasive Disease Presenting with Acquired Fanconi Syndrome, Which Resolved on Recovery.
Article in European journal of case reports in internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: West Nile virus (WNV) is a mosquito-borne flavivirus that can cause neuroinvasive disease. Renal involvement is uncommon and acquired Fanconi syndrome has not been previously described in association with WNV. Case presentation: An 81-year-old male from Cyprus presented with fever, headache, disorientation, and signs of meningoencephalitis. Cerebrospinal fluid (CSF) analysis and neuroimaging supported the diagnosis of viral encephalitis. Extensive microbiological testing revealed WNV ribonucleic acid in urine and blood, but not in the CSF. The patient developed persistent hypokalaemia, metabolic acidosis, hypomagnesemia, and hypouricemia, with elevated fractional excretion of these solutes-findings consistent with Fanconi syndrome. Acyclovir was discontinued, and supportive treatment was provided. Renal function and electrolyte levels normalized by day 9. At 2-month follow-up, the patient had fully recovered with normal renal parameters. Conclusion: Renal complications of WNV are rarely documented and this case of WNV associated acquired Fanconi syndrome underscores the importance of evaluating kidney function and electrolyte status in WNV-infected patients. Early recognition of tubular dysfunction may prevent complications and improve outcomes. LEARNING POINTS: While renal complications of West Nile virus (WNV) are documented in rare cases, this is the first reported case of WNV-associated Fanconi syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.